Thu Jan 30 11:43:36 UTC 2025: ## Mixed Signals in Indian Markets: Dr. Agarwal IPO Underwhelms, Shapoorji Pallonji Seeks Debt Refinancing

**Mumbai, India** – India’s financial markets are showing a mixed bag today, with a muted response to the Dr. Agarwal’s Healthcare IPO contrasting with news of significant debt refinancing for the Shapoorji Pallonji Group.

Dr. Agarwal’s Healthcare, a leading eye care provider, saw its initial public offering (IPO) garner only 7% subscription on its second day. Priced between Rs 382-402 per share, the IPO, aiming to raise Rs 3,025 crore, has been met with caution from analysts like StoxBox, who cite overvaluation and inconsistent financial performance. While boasting a 25% market share in India’s eye care sector and a strong projected long-term growth, the IPO’s high valuation (134 times FY24 EPS) and modest grey market premium (GMP of Rs 12) have dampened investor enthusiasm. The company reported a net profit of Rs 39.56 crore on revenue of Rs 837.94 crore for the six months ending September 30, 2024.

In contrast, the Shapoorji Pallonji Group is reportedly close to finalizing a deal to refinance approximately $3.2 billion in outstanding debt with a group of global alternative asset investors. This follows a previous $2.6 billion loan secured in 2021.

Elsewhere in the market, CLN Energy’s shares debuted on the BSE SME platform at Rs 256, a 2.4% premium over its IPO price. The Traders Gurukul-organized BOTS (India’s Largest Regional Retail Option Traders Summit) continues to provide insights into the dynamic crypto market. Moneycontrol will continue to provide updates on these and other market developments.

Read More